Effect of levosimendan on clinical outcomes in adult patients undergoing cardiac surgery: A meta-analysis of randomized controlled trials

Interactive Cardiovascular and Thoracic Surgery

Volumn 26, Issue 6, 2018, Pages 1016-1026

  Zhou, Xiaoyang ^a   Hu, Caibao ^b   Xu, Zhaojun ^a   Liu, Peng ^a   Zhang, Yuchu ^a   Sun, Lingling ^a   Wang, Yang ^a   Gao, Xiaofei ^c  

^a NINGBO NO 2 HOSPITAL   (China)

^b ZHEJIANG HOSPITAL   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Cardiac surgery; Levosimendan; Meta analysis; Mortality; Outcomes

Indexed keywords

LEVOSIMENDAN; PHOSPHODIESTERASE III INHIBITOR; SIMENDAN;

ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL OUTCOME; DRUG EFFECT; HEART SURGERY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL MORTALITY; SYSTEMATIC REVIEW; ADULT; GLOBAL HEALTH; HEART DISEASE; INCIDENCE; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL RATE; TRENDS;

ADULT; CARDIAC SURGICAL PROCEDURES; GLOBAL HEALTH; HEART DISEASES; HUMANS; INCIDENCE; LENGTH OF STAY; PHOSPHODIESTERASE 3 INHIBITORS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIMENDAN; SURVIVAL RATE;

EID: 85048125255     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivy017     Document Type: Article

References (41)

1. Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF, Namerow PB. Coronary artery bypass grafting in patients with low ejection fraction. Circulation 2005;112:I344-50.
2. Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Kini AS, Adams DH. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function. Ann Thorac Surg 2007;84:808-16.
3. Aksun M, Karahan N, Adanir T, Aran G, Yetkin U, Oztürk T et al. Timing of levosimendan in cardiac surgery. Anadolu Kardiyol Derg 2009;9: 223-30.
4. Sorsa T, Pollesello P, Rosevear PR, Drakenberg T, Kilpeläinen I. Stereoselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization. Eur J Pharmacol 2004;486:1-8.
5. Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL et al. The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome. Rev Esp Cardiol 2008;61:471-9.
6. Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol 2012;17:125-30.
7. Sahin V, Uyar IS, Gul I, Akpinar MB, Abacilar AF, Uc H et al. Evaluation of myocardial contractility determination with tissue tracking echocardiography after levosimendan infusion in patients with poor left ventricular function and hemodynamics. Heart Surg Forum 2014;17:E313-18.
8. Landoni G, Mizzi A, Biondi-Zoccai G, Bruno G, Bignami E, Corno L et al. Reducing mortality in cardiac surgery with levosimendan: a metaanalysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2010;24:51-7.
9. Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2013; 27:1224-32.
10. Lim JY, Deo SV, Rababa'h A, Altarabsheh SE, Cho YH, Hang D et al. Levosimendan reduces mortality in adults with left ventricular dysfunction undergoing cardiac surgery: a systematic review and meta-analysis. J Card Surg 2015;30:547-54.
11. Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F et al. Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med 2017;376:2021-31.
12. Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med 2017;376:2032-42.
13. Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J et al. Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass The LICORN randomized clinical trial. JAMA 2017;318:548-56.
14. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.handbook.cochrane.org.
15. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
16. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions, Vol. 5. Chichester: Wiley Online Library, 2008.
17. Baysal A, Yanartas M, Dogukan M, Gundogus N, Kocak T, Koksal C. Levosimendan improves renal outcome in cardiac surgery: a randomized trial. J Cardiothorac Vasc Anesth 2014;28:586-94.
18. Alvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodŕguez J et al. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 2006;59:338-45.
19. Al-Shawaf E, Ayed A, Vislocky I, Radomir B, Dehrab N, Tarazi R. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J Cardiothorac Vasc Anesth 2006;20:353-7.
20. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007;104:766-73.
21. Järvelä K, Maaranen P, Sisto T, Ruokonen E. Levosimendan in aortic valve surgery: cardiac performance and recovery. J Cardiothorac Vasc Anesth 2008;22:693-8.
22. Eriksson HI, Jalonen JR, Heikkinen LO, Kivikko M, Laine M, Leino KA et al. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg 2009;87:448-54.
23. Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P et al. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009;102:198-204.
24. Leppikangas H, Järvelä K, Sisto T, Maaranen P, Virtanen M, Lehto P et al. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth 2011;106:298-304.
25. Lahtinen P, Pitkänen O, Pölönen P, Turpeinen A, Kiviniemi V, Uusaro A. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. Crit Care Med 2011;39:2263-70.
26. Lomivorotov VV, Boboshko VA, Efremov SM, Kornilov IA, Chernyavskiy AM, Lomivorotov VN et al. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients. J Cardiothorac Vasc Anesth 2012;26:596-603.
27. Dogan OF. Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study. Heart Surg Forum 2013; 16:E287-94.
28. Gandham R, Syamasundar A, Ravulapalli H, Karthekeyan RB, Vakamudi M, Kodalli R et al. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair/replacement for severe mitral stenosis. Ann Card Anaesth 2013; 16:11-15.
29. Ersoy O, Boysan E, Unal EU, Yay K, Yener U, Cicekcioglu F et al. Effectiveness of prophylactic levosimendan in high-risk valve surgery patients. Cardiovasc J Afr 2013;24:260-4.
30. Karthekeyan RB, Chandrasekaran N, Kodalli RK, Sundar AS, Vakamudi M, Ravulapali H et al. Effect of levosimendan on hemodynamic changes in patients undergoing off-pump coronary artery bypass grafting: a randomized controlled study. Ann Card Anaesth 2013;16:94.
31. Erb J, Beutlhauser T, Feldheiser A, Schuster B, Treskatsch S, Grubitzsch H et al. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery. J Int Med Res 2014;42:750-64.
32. Sharma P, Malhotra A, Gandhi S, Garg P, Bishnoi A, Gandhi H. Preoperative levosimendan in ischemic mitral valve repair. Asian Cardiovasc Thorac Ann 2014;22:539-45.
33. Shah B, Sharma P, Brahmbhatt A, Shah R, Rathod B, Shastri N et al. Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study. Indian J Pharmacol 2014;46:29-34.
34. Juhl-Olsen P, Jakobsen CJ, Rasmussen LA, Bhavsar R, Klaaborg KE, Frederiksen CA et al. Effects of levosimendan in patients with left ventricular hypertrophy undergoing aortic valve replacement. Acta Anaesthesiol Scand 2015;59:65-77.
35. Sahu MK, Das A, Malik V, Subramanian A, Singh SP, Hote M. Comparison of levosimendan and nitroglycerine in patients undergoing coronary artery bypass graft surgery. Ann Card Anaesth 2016;19:52-8.
36. Mishra A, Kumar B, Dutta V, Arya VK, Mishra AK. Comparative effect of levosimendan and milrinone in cardiac surgery patients with pulmonary hypertension and left ventricular dysfunction. J Cardiothorac Vasc Anesth 2016;30:639-46.
37. Anastasiadis K, Antonitsis P, Vranis K, Kleontas A, Asteriou C, Grosomanidis V et al. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study. Interact CardioVasc Thorac Surg 2016;23:740-7.
38. Atalay H, Temizturk Z, Azboy D, Colak S, Atalay A, Dogan OF et al. Levosimendan use increases cardiac performance after coronary artery bypass grafting in end-stage renal disease patients. Heart Surg Forum 2016;19:E230-6.
39. Giannini C, Petronio AS, Fiorelli F, Liga R, Spontoni P, De Carlo M et al. Effects of levosimendan in patients with severe functional mitral regurgitation undergoing MitraClip implantation. J Cardiovasc Med (Hagerstown) 2017;18:679-86.
40. Kandasamy A, Simon HA, Murthy P, Annadurai M, Ali MM, Ramanathan G. Comparison of levosimendan versus dobutamine in patients with moderate to severe left ventricular dysfunction undergoing off-pump coronary artery bypass grafting: a randomized prospective study. Ann Card Anaesth 2017;20:200-6.
41. Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care 2013;17:R2.